title: Effects of isatin on rotational behavior and DA levels in caudate putamen in Parkinsonian rats.
abstract: Isatin was a potent endogenous monoamine oxidase (MAO) inhibitor that is more active against MAO-B than MAO-A. The acute effects of isatin on apomorphine (APO)-induced rotations were evaluated in Parkinsonian rats induced by 6-hydroxydopamine (6-OHDA) lesion. Furthermore, the effects of isatin on DA release in caudate putamen (CPu) of model and normal rats were monitored using fast cyclic voltammetry (FCV). The contents of monoamine transmitters and their metabolites in CPu of model and normal rats were also analyzed by high performance liquid chromatography with electrochemical detection after administration of isatin. Here we show that isatin (100 mg/kg, i.p.) apparently inhibited APO-induced rotations of Parkinsonian rats to 39.1+/-3.7% of the control (n=12), while it had no apparent effects on electrical stimuli-induced DA release either in normal rats or in model rats. In addition, the content of 5-hydroxytryptamine but not DA was increased in both normal rats and model rats after isatin (100 mg/kg, i.p.) was administered (P<0.01, n=6). The content of 5-hydroxyindole acetic acid was not changed. These results suggest that isatin cannot increase DA levels in rat CPu. Therefore, the effects of isatin on APO-induced rotations of our Parkinsonian rats could not attribute to its inhibition of DA catabolism as a MAO inhibitor.
authors.affiliation: Department of Physiology, School of Medicine, Qingdao University, 38 Deng-Zhou Road, Qingdao 266021, PR China.
authors.forename: Y
authors.initials: Y
authors.lastname: Zhou
authors.forename: Z Q
authors.initials: ZQ
authors.lastname: Zhao
authors.forename: J X
authors.initials: JX
authors.lastname: Xie
mesh_terms: D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D015306:Biogenic Monoamines / Q000378:metabolism; D002421:Caudate Nucleus / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D007510:Isatin / Q000494:pharmacology*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D018377:Neurotransmitter Agents / Q000378:metabolism; D020734:Parkinsonian Disorders / Q000503:physiopathology*; D011699:Putamen / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D012016:Reference Values; D012399:Rotation; D013239:Stereotyped Behavior / Q000187:drug effects*
chemical_list: D015306:Biogenic Monoamines; D008996:Monoamine Oxidase Inhibitors; D018377:Neurotransmitter Agents; D007510:Isatin; D001058:Apomorphine; D004298:Dopamine